Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y6MH
|
||||
Former ID |
DCL001015
|
||||
Drug Name |
Tebipenem
|
||||
Synonyms |
Tebipenem [INN]
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Nicotine dependence; Obesity [ICD9: 278, 305.1; ICD10:E66, F17] | Phase 2 | [536122] | ||
Company |
Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H21N3O4S2
|
||||
Canonical SMILES |
CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)C(C)O
|
||||
InChI |
1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1
|
||||
InChIKey |
GXXLUDOKHXEFBQ-YJFSRANCSA-N
|
||||
CAS Number |
CAS 158681-13-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Antagonist | [536122] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.